AIR-001 (AIRNA Corp)

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameAIR-001 (AIRNA Corp)
Drug Alias NameAIR-001
ClassificationCell and gene therapy > Gene therapy > Gene editing > RNA editing
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaGeorgia +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAIRNA Corp
China Registration ClassN/A

Develop Information

Active CompaniesAIRNA Corp
Inactive CompaniesN/A
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A